Generation of inhibitory monoclonal antibodies targeting matrix metalloproteinase-14 by motif grafting and CDR optimization
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Generation of inhibitory monoclonal antibodies targeting matrix metalloproteinase-14 by motif grafting and CDR optimization
Authors
Keywords
-
Journal
PROTEIN ENGINEERING DESIGN & SELECTION
Volume 30, Issue 2, Pages 113-118
Publisher
Oxford University Press (OUP)
Online
2016-11-24
DOI
10.1093/protein/gzw070
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SAbPred: a structure-based antibody prediction server
- (2016) James Dunbar et al. NUCLEIC ACIDS RESEARCH
- Active-site MMP-selective antibody inhibitors discovered from convex paratope synthetic libraries
- (2016) Dong Hyun Nam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Direct production of functional matrix metalloproteinase-14 without refolding or activation and its application for in vitro inhibition assays
- (2015) Dong Hyun Nam et al. BIOTECHNOLOGY AND BIOENGINEERING
- Blockade of MMP14 Activity in Murine Breast Carcinomas: Implications for Macrophages, Vessels, and Radiotherapy
- (2015) Eleanor I. Ager et al. JNCI-Journal of the National Cancer Institute
- Blockade of MMP14 Activity in Murine Breast Carcinomas: Implications for Macrophages, Vessels, and Radiotherapy
- (2015) Eleanor I. Ager et al. JNCI-Journal of the National Cancer Institute
- Rational Design of a Humanized Glucagon-Like Peptide-1 Receptor Agonist Antibody
- (2014) Yong Zhang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- ZDOCK server: interactive docking prediction of protein-protein complexes and symmetric multimers
- (2014) B. G. Pierce et al. BIOINFORMATICS
- Selective matrix metalloproteinase (MMP) inhibitors in cancer therapy: Ready for prime time?
- (2010) Stanley Zucker et al. CANCER BIOLOGY & THERAPY
- A novel and selective membrane type-1 matrix metalloproteinase (MT1-MMP) inhibitor reduces cancer cell motility and tumor growth
- (2010) Juho Suojanen et al. CANCER BIOLOGY & THERAPY
- Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain
- (2010) Rishabh Dev et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis
- (2009) Laetitia Devy et al. CANCER RESEARCH
- Matrix metalloproteinase proteomics: substrates, targets, and therapy
- (2009) Charlotte J Morrison et al. CURRENT OPINION IN CELL BIOLOGY
- IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding
- (2009) R. Z. Cer et al. NUCLEIC ACIDS RESEARCH
- Engineering a Single-Chain Fv Antibody to αvβ6 Integrin Using the Specificity-Determining Loop of a Foot-and-Mouth Disease Virus
- (2008) Heide Kogelberg et al. JOURNAL OF MOLECULAR BIOLOGY
- Structure of an Fab–Protease Complex Reveals a Highly Specific Non-canonical Mechanism of Inhibition
- (2008) Christopher J. Farady et al. JOURNAL OF MOLECULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More